Home › Stocks › ABUS › All Fund Holders
ABUS — ARBUTUS BIOPHARMA CORP · All Fund Holders
Funds holding (latest): 37 · Reported value held: $297.72M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Morgan Stanley history | Q2 2026 | 17.70M | $84.95M | 0.01% | Reduce |
| BlackRock Inc history | Q2 2026 | 13.77M | $66.08M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 9.24M | $44.46M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 4.12M | $19.77M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 3.51M | $16.83M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 2.65M | $12.70M | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 2.47M | $11.84M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.43M | $6.87M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 1.42M | $6.81M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 879.24K | $4.22M | 0.00% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 650.70K | $3.12M | 0.00% | New |
| Millennium Management history | Q1 2026 | 642.45K | $2.89M | 0.00% | New |
| Wellington Management Group history | Q2 2026 | 461.65K | $2.22M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 454.12K | $2.18M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 404.70K | $1.94M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 381.86K | $1.83M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 267.19K | $1.28M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 250.91K | $1.20M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 249.21K | $1.20M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 170.45K | $818.18K | 0.00% | Add |
| Marshall Wace history | Q3 2022 | 392.93K | $751.00K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 147.99K | $710.37K | 0.00% | Add |
| Balyasny Asset Management history | Q1 2026 | 125.52K | $564.85K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 98.22K | $459.69K | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 84.99K | $407.93K | 0.00% | New |
| Franklin Resources history | Q2 2025 | 104.42K | $322.67K | 0.00% | Add |
| Janus Henderson Group history | Q4 2025 | 60.90K | $293.23K | 0.00% | Hold |
| Point72 Asset Management history | Q4 2023 | 105.00K | $262.50K | 0.00% | New |
| Manulife Financial history | Q2 2026 | 44.30K | $212.66K | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 31.74K | $152.36K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 26.38K | $126.62K | 0.00% | Add |
| Lazard Asset Management history | Q2 2026 | 23.72K | $113.87K | 0.00% | New |
| Principal Global Investors history | Q2 2026 | 12.30K | $59.03K | 0.00% | Add |
| Amundi US history | Q2 2026 | 11.88K | $57.01K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 1.69K | $8.11K | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2023 | 321.13K | $739 | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 133.83K | $643 | 0.00% | Add |